NasdaqCM:QMMM
NasdaqCM:QMMMMedia

QMMM Holdings (QMMM) Reports Disappointing Half-Year Earnings With US$1.38 Million Net Loss

QMMM Holdings (QMMM) announced disappointing half-year earnings on August 29, 2025, with a sales drop to USD 1.23 million and an increased net loss of USD 1.38 million compared to the previous year. Despite this, the company's stock experienced a remarkable 7530.83% increase last quarter. This significant price move came amid broader market trends, where the tech-heavy Nasdaq Composite hit a record high. Concurrent events for QMMM, such as management reshuffles and the completion of an $8...
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025

Apogee Therapeutics (APGE) made headlines with the acceptance of data from its Phase 2 APEX trial for APG777 at the EADV Congress, signaling its efforts in tackling atopic dermatitis. Over the last month, Apogee’s share price rose 1.55%, reflecting a performance consistent with the broader market's 1.8% increase. While its clinical developments added momentum, other market trends such as the Nasdaq’s record highs and tech sector rallies also buoyed investor confidence. These factors...
NYSE:PAY
NYSE:PAYDiversified Financial

Paymentus Holdings (PAY) Sees Sales Surge to US$280 Million in Q2 2025

Paymentus Holdings (PAY) announced its second quarter results on August 4, 2025, showcasing significant growth with sales increasing to $280 million from $197 million the previous year, and net income rising to $15 million from $9 million. Despite these positive earnings, the company's price movement remained relatively flat over the last quarter in line with broader market trends, which also exhibited minor fluctuations. While company-specific results and corporate guidance might have added...